These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38261153)

  • 1. Validating the usefulness of Sudoscan in ATTRv: a single centre experience.
    Moreno-Moraleda E; González-Moreno J; Cisneros-Barroso E; Ribot-Sansó MA; Ripoll-Vera T; Descals C; Uson M; Montalà JC; Figuerola A; Rodríguez A; Losada I
    Neurol Sci; 2024 Jun; 45(6):2859-2867. PubMed ID: 38261153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic accuracy of Sudoscan in transthyretin familial amyloid polyneuropathy.
    Castro J; Miranda B; Castro I; de Carvalho M; Conceição I
    Clin Neurophysiol; 2016 May; 127(5):2222-7. PubMed ID: 27072093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative sudomotor test helps differentiate transthyretin familial amyloid polyneuropathy from chronic inflammatory demyelinating polyneuropathy.
    Fortanier E; Delmont E; Verschueren A; Attarian S
    Clin Neurophysiol; 2020 May; 131(5):1129-1133. PubMed ID: 32217467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of electrochemical skin conductance measurement using Sudoscan® in the assessment of patients with familial amyloid polyneuropathy.
    Lefaucheur JP; Zouari HG; Gorram F; Nordine T; Damy T; Planté-Bordeneuve V
    Clin Neurophysiol; 2018 Aug; 129(8):1565-1569. PubMed ID: 29883834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of autonomic innervation of the foot in familial amyloid polyneuropathy.
    Zouari HG; Ng Wing Tin S; Wahab A; Damy T; Lefaucheur JP
    Eur J Neurol; 2019 Jan; 26(1):94-e10. PubMed ID: 30102818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pupillometric findings in ATTRv patients and carriers: results from a single-centre experience.
    Romano A; Guglielmino V; Di Paolantonio A; Bisogni G; Sabatelli M; Della Marca G; Minnella AM; Maceroni M; Bellavia S; Scala I; Sabatelli E; Rollo E; Luigetti M
    Amyloid; 2022 Dec; 29(4):270-275. PubMed ID: 36066019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between a commercial electrophysiological test of sudomotor function and intraepidermal nerve fiber density in hereditary transthyretin amyloidosis.
    Masuda T; Misumi Y; Nomura T; Yamakawa S; Tasaki M; Obayashi K; Ando Y; Ueda M
    Muscle Nerve; 2024 Jan; 69(1):99-102. PubMed ID: 37960924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A description of variant transthyretin amyloidosis (ATTRv) stage 1 patients and asymptomatic carriers in Spain: the EMPATIa study.
    Galán Dávila L; Martinez Valle F; Buades Reinés J; Gonzalez-Moreno J; Losada López I; Sevilla T; Muñoz Beamud F; Bárcena Llona JE; Romero Acebal M; Setaro F; Primiano D; Tarilonte P
    Orphanet J Rare Dis; 2024 Sep; 19(1):323. PubMed ID: 39242501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-Echo Turbo Spin Echo and 12-Echo Multi Spin Echo Sequences as Equivalent Techniques for Obtaining T2-Relaxometry Data: Application in Symptomatic and Asymptomatic Hereditary Transthyretin Amyloidosis as a Surrogate Disease.
    Poncelet A; Weiler M; Hegenbart U; Sam G; Schönland S; Purrucker JC; Hayes JM; Hund E; Bendszus M; Heiland S; Kollmer J
    Invest Radiol; 2022 May; 57(5):301-307. PubMed ID: 34839307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction.
    Casellini CM; Parson HK; Richardson MS; Nevoret ML; Vinik AI
    Diabetes Technol Ther; 2013 Nov; 15(11):948-53. PubMed ID: 23889506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal values of sudomotor function assessed by electrochemical skin conductance in African population.
    Lare BP; Jost J; Apetse K; Salle L; Preux PM; Balogou A; Magne J
    Rev Neurol (Paris); 2024 Mar; 180(3):163-170. PubMed ID: 37813768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing sudomotor impairment in patients with peripheral neuropathy: Comparison between electrochemical skin conductance and skin biopsy.
    Duchesne M; Richard L; Vallat JM; Magy L
    Clin Neurophysiol; 2018 Jul; 129(7):1341-1348. PubMed ID: 29729587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of axonal damage to favor early diagnosis in variant transthyretin amyloidosis (A-ATTRv).
    González-Moreno J; Gragera-Martínez Á; Rodríguez A; Borrachero-Garro C; García-Garrido S; Barceló C; Manovel-Sánchez A; Ribot-Sansó MA; Ibargüen-González L; Gomila R; Muñoz-Beamud F; Losada-López I; Cisneros-Barroso E
    Sci Rep; 2024 Jan; 14(1):581. PubMed ID: 38182630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudoscan in the evaluation and follow-up of patients and carriers with TTR mutations: experience from an Italian Centre.
    Luigetti M; Bisogni G; Romano A; Di Paolantonio A; Barbato F; Primicerio G; Rossini PM; Servidei S; Sabatelli M
    Amyloid; 2018 Dec; 25(4):242-246. PubMed ID: 30638075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis.
    Louwsma J; Brunger AF; Bijzet J; Kroesen BJ; Roeloffzen WWH; Bischof A; Kuhle J; Drost G; Lange F; Kuks JBM; Gans ROB; Hazenberg BPC; Nienhuis HLA
    Amyloid; 2021 Mar; 28(1):50-55. PubMed ID: 32883119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and apparative investigation of large and small nerve fiber impairment in mixed cohort of ATTR-amyloidosis: impact on patient management and new insights in wild-type.
    Papagianni A; Ihne S; Zeller D; Morbach C; Üçeyler N; Sommer C
    Amyloid; 2022 Mar; 29(1):14-22. PubMed ID: 34632904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudoscan as a noninvasive tool to assess sudomotor dysfunction in patients with Fabry disease: results from a case-control study.
    Sahuc P; Chiche L; Dussol B; Pouget J; Franques J
    Ther Clin Risk Manag; 2016; 12():135-8. PubMed ID: 26893567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis.
    Kollmer J; Hegenbart U; Kimmich C; Hund E; Purrucker JC; Hayes JM; Lentz SI; Sam G; Jende JME; Schönland SO; Bendszus M; Heiland S; Weiler M
    Ann Clin Transl Neurol; 2020 May; 7(5):799-807. PubMed ID: 32333729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin and clusterin levels in type 2 diabetes mellitus: differential association with peripheral autonomic nerve function.
    Maser RE; James Lenhard M; Pohlig RT; Babu Balagopal P
    Neurol Sci; 2017 Sep; 38(9):1645-1650. PubMed ID: 28638999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early diagnostic tools in hereditary amyloidosis related to transthyretin (hATTR) V30M autonomic neuropathy.
    de Campos CF; Conceição I; Castro I
    Amyloid; 2019; 26(sup1):35-36. PubMed ID: 31343294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.